Unknown

Dataset Information

0

Polycystin-1 is required for insulin-like growth factor 1-induced cardiomyocyte hypertrophy.


ABSTRACT: Cardiac hypertrophy is the result of responses to various physiological or pathological stimuli. Recently, we showed that polycystin-1 participates in cardiomyocyte hypertrophy elicited by pressure overload and mechanical stress. Interestingly, polycystin-1 knockdown does not affect phenylephrine-induced cardiomyocyte hypertrophy, suggesting that the effects of polycystin-1 are stimulus-dependent. In this study, we aimed to identify the role of polycystin-1 in insulin-like growth factor-1 (IGF-1) signaling in cardiomyocytes. Polycystin-1 knockdown completely blunted IGF-1-induced cardiomyocyte hypertrophy. We then investigated the molecular mechanism underlying this result. We found that polycystin-1 silencing impaired the activation of the IGF-1 receptor, Akt, and ERK1/2 elicited by IGF-1. Remarkably, IGF-1-induced IGF-1 receptor, Akt, and ERK1/2 phosphorylations were restored when protein tyrosine phosphatase 1B was inhibited, suggesting that polycystin-1 knockdown deregulates this phosphatase in cardiomyocytes. Moreover, protein tyrosine phosphatase 1B inhibition also restored IGF-1-dependent cardiomyocyte hypertrophy in polycystin-1-deficient cells. Our findings provide the first evidence that polycystin-1 regulates IGF-1-induced cardiomyocyte hypertrophy through a mechanism involving protein tyrosine phosphatase 1B.

SUBMITTER: Fernandez C 

PROVIDER: S-EPMC8372926 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2582541 | biostudies-literature
| S-EPMC3647008 | biostudies-literature
| S-EPMC3856010 | biostudies-literature
2021-01-05 | GSE164187 | GEO
| S-EPMC1855421 | biostudies-literature
| S-EPMC2845429 | biostudies-literature